Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMZN Amazon.com	$234.11 +0.6%	$256.40	$196.00 ▼ $278.56	$2.50T	1.45	44.33 million shs	59.08 million shs
HIMS Hims & Hers Health	$33.00 -1.6%	$27.29	$13.74 ▼ $70.43	$7.76B	2.37	18.86 million shs	12.51 million shs
LLY Eli Lilly and Company	$1,110.37 +0.8%	$1,022.46	$623.78 ▼ $1,182.73	$1.04T	0.53	3.11 million shs	3.31 million shs
NVO Novo Nordisk A/S	$47.38 +3.3%	$43.29	$35.12 ▼ $71.79	$204.85B	0.78	12.40 million shs	17.65 million shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMZN Amazon.com	-4.75%	-5.38%	-12.59%	+12.33%	+11.02%
HIMS Hims & Hers Health	-5.19%	+11.63%	+41.71%	+57.06%	-47.89%
LLY Eli Lilly and Company	+0.45%	-2.34%	+3.48%	+22.36%	+44.57%
NVO Novo Nordisk A/S	+6.25%	+4.67%	+2.21%	+24.40%	-37.77%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMZN Amazon.com	$234.11 +0.6%	$256.40	$196.00 ▼ $278.56	$2.50T	1.45	44.33 million shs	59.08 million shs
HIMS Hims & Hers Health	$33.00 -1.6%	$27.29	$13.74 ▼ $70.43	$7.76B	2.37	18.86 million shs	12.51 million shs
LLY Eli Lilly and Company	$1,110.37 +0.8%	$1,022.46	$623.78 ▼ $1,182.73	$1.04T	0.53	3.11 million shs	3.31 million shs
NVO Novo Nordisk A/S	$47.38 +3.3%	$43.29	$35.12 ▼ $71.79	$204.85B	0.78	12.40 million shs	17.65 million shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMZN Amazon.com	-4.75%	-5.38%	-12.59%	+12.33%	+11.02%
HIMS Hims & Hers Health	-5.19%	+11.63%	+41.71%	+57.06%	-47.89%
LLY Eli Lilly and Company	+0.45%	-2.34%	+3.48%	+22.36%	+44.57%
NVO Novo Nordisk A/S	+6.25%	+4.67%	+2.21%	+24.40%	-37.77%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMZN Amazon.com	2.95	Moderate Buy	$312.78	33.60% Upside
HIMS Hims & Hers Health	2.13	Hold	$29.37	-11.01% Downside
LLY Eli Lilly and Company	2.87	Moderate Buy	$1,230.89	10.85% Upside
NVO Novo Nordisk A/S	2.17	Hold	$65.56	38.38% Upside

Current Analyst Ratings Breakdown

Latest HIMS, LLY, NVO, and AMZN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/22/2026	LLY Eli Lilly and Company	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
6/22/2026	LLY Eli Lilly and Company	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$1,050.00 ➝ $1,135.00
6/19/2026	NVO Novo Nordisk A/S	Nordea Equity Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy
6/18/2026	AMZN Amazon.com	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
6/17/2026	HIMS Hims & Hers Health	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$29.00 ➝ $39.00
6/16/2026	AMZN Amazon.com	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
6/15/2026	LLY Eli Lilly and Company	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
6/11/2026	AMZN Amazon.com	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$330.00
6/9/2026	LLY Eli Lilly and Company	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$1,330.00 ➝ $1,350.00
6/9/2026	AMZN Amazon.com	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
6/8/2026	LLY Eli Lilly and Company	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform

(Data available from 6/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMZN Amazon.com	$742.78B	3.39	$13.44 per share	17.42	$38.29 per share	6.11
HIMS Hims & Hers Health	$2.37B	3.22	$0.82 per share	40.08	$2.38 per share	13.87
LLY Eli Lilly and Company	$65.18B	16.04	$25.33 per share	43.84	$28.07 per share	39.56
NVO Novo Nordisk A/S	$46.80B	4.52	$4.84 per share	9.79	$6.58 per share	7.20

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMZN Amazon.com	$77.67B	$8.36	28.00	23.36	1.74	12.22%	19.92%	9.86%	7/30/2026 (Estimated)
HIMS Hims & Hers Health	$128.37M	-$0.09	N/A	66.00	47.94	-0.56%	6.10%	1.52%	8/10/2026 (Estimated)
LLY Eli Lilly and Company	$20.64B	$28.15	39.44	24.90	1.20	34.98%	105.77%	23.76%	8/5/2026 (Estimated)
NVO Novo Nordisk A/S	$15.51B	$4.26	11.12	13.85	4.10	37.23%	63.31%	22.19%	8/5/2026 (Estimated)

Latest HIMS, LLY, NVO, and AMZN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/11/2026	Q1 2026	HIMS Hims & Hers Health	$0.04	-$0.40	-$0.44	-$0.40	$616.84 million	$608.10 million
5/6/2026	Q1 2026	NVO Novo Nordisk A/S	$0.87	$1.04	+$0.17	$1.69	$10.86 billion	$10.85 billion
4/30/2026	Q1 2026	LLY Eli Lilly and Company	$6.97	$8.55	+$1.58	$8.26	$17.82 billion	$19.80 billion
4/29/2026	Q1 2026	AMZN Amazon.com	$1.63	$2.78	+$1.15	$2.78	$177.28 billion	$181.52 billion
3/31/2026	Q1 2026	NVO Novo Nordisk A/S	N/A	$1.0270	N/A	$1.69	N/A	$10.85 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMZN Amazon.com	$0.20	0.09%	N/A	2.39%	N/A
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
LLY Eli Lilly and Company	$6.92	0.62%	+15.18%	24.58%	11 Years
NVO Novo Nordisk A/S	$1.75	3.69%	+21.74%	41.08%	N/A

Latest HIMS, LLY, NVO, and AMZN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/22/2026	LLY Eli Lilly and Company	quarterly	$1.73	0.63%	8/14/2026	8/14/2026	9/10/2026
5/4/2026	LLY Eli Lilly and Company	quarterly	$1.73	0.69%	5/15/2026	5/15/2026	6/10/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMZN Amazon.com	0.27	1.18	1.01
HIMS Hims & Hers Health	2.18	1.69	1.56
LLY Eli Lilly and Company	1.26	1.50	1.10
NVO Novo Nordisk A/S	0.59	0.79	0.56

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMZN Amazon.com	72.20%
HIMS Hims & Hers Health	63.52%
LLY Eli Lilly and Company	82.53%
NVO Novo Nordisk A/S	11.54%

Insider Ownership

Company	Insider Ownership
AMZN Amazon.com	8.90%
HIMS Hims & Hers Health	11.76%
LLY Eli Lilly and Company	0.14%
NVO Novo Nordisk A/S	0.07%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMZN Amazon.com	1,576,000	10.76 billion	9.80 billion	Optionable
HIMS Hims & Hers Health	2,442	231.46 million	204.24 million	Optionable
LLY Eli Lilly and Company	50,000	941.74 million	940.42 million	Optionable
NVO Novo Nordisk A/S	69,505	4.47 billion	4.46 billion	Optionable

HIMS, LLY, NVO, and AMZN Headlines

Recent News About These Companies

Novo Nordisk A/S (NVO) Primary Owner to Open Obesity Drug Incubators Across Europe

June 23 at 5:53 PM | finance.yahoo.com

Novo Nordisk A/S (NVO) Primary Owner to Open Obesity Drug Incubators Across Europe

June 23 at 5:10 PM | insidermonkey.com

Forget Novo Nordisk. Pfizer's Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait

June 23 at 1:55 PM | 247wallst.com

NVO Gains as Foundation Unveils EUR 60M Cardiometabolic Research Push

June 23 at 12:52 PM | finance.yahoo.com

NVO Gains as Foundation Unveils EUR 60M Cardiometabolic Research Push

June 23 at 12:11 PM | zacks.com

Novo Nordisk: The Selloff Looks Like A Gift, And I'm Buying

June 23 at 9:00 AM | seekingalpha.com

FFG Partners LLC Takes Position in Novo Nordisk A/S $NVO

June 23 at 4:15 AM | marketbeat.com

Novo Nordisk stock is surging Monday: What's driving the action?

June 22 at 8:57 PM | msn.com

Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk

June 22 at 8:15 PM | fool.com

A Look at Novo Nordisk AS (NVO) After 6.2% Gain -- GF Value $144.58 vs Price $45.88

June 22 at 6:01 PM | gurufocus.com

Novo Nordisk (NVO) Stock Surges 6.55% on Oral Wegovy UK Approval

June 22 at 3:57 PM | blockonomi.com

Here is why Novo Nordisk A/S (NVO) is among the Best Longevity and Anti-Aging Stocks to Buy

June 22 at 3:57 PM | finance.yahoo.com

Here's Why You Should Add LXRX Stock to Your Portfolio Now

June 22 at 3:57 PM | finance.yahoo.com

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

June 22 at 3:57 PM | finance.yahoo.com

Novo Nordisk's Wegovy pill headlines mask complicated competitive reality

June 22 at 8:43 AM | proactiveinvestors.co.uk

South Africa court bars iDexis from selling compounded Ozempic in Novo Nordisk case

June 22 at 6:42 AM | reuters.com

Weight loss pill to reshape spending habits of millions of people, study finds

June 21 at 7:41 PM | uk.finance.yahoo.com

Novo Nordisk Data Breach: Hackers Claim To Have Stolen Drug Research, Trial Data And AI Models

June 21 at 2:40 PM | finance.yahoo.com

3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend (NVO)

...

June 21 at 11:40 AM | marketbeat.com

Novo Nordisk (CPSE:NOVO B) Launches CardioMetabolic Bridge To Speed New Obesity And Diabetes Therapies

June 20 at 6:26 PM | finance.yahoo.com

Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock?

June 20 at 12:15 PM | fool.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

HIMS, LLY, NVO, and AMZN Company Descriptions

Amazon.com NASDAQ:AMZN

$234.11 +1.32 (+0.57%)

Closing price 04:00 PM Eastern

Extended Trading

$233.51 -0.60 (-0.26%)

As of 08:00 PM Eastern

Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, Fire tablets, Fire TVs, Echo, Ring, Blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. Amazon.com, Inc. was incorporated in 1994 and is headquartered in Seattle, Washington.

Hims & Hers Health NYSE:HIMS

$33.00 -0.54 (-1.61%)

Closing price 03:58 PM Eastern

Extended Trading

$33.01 +0.01 (+0.03%)

As of 07:59 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Eli Lilly and Company NYSE:LLY

$1,110.37 +8.29 (+0.75%)

Closing price 03:58 PM Eastern

Extended Trading

$1,106.79 -3.58 (-0.32%)

As of 07:59 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Novo Nordisk A/S NYSE:NVO

$47.38 +1.50 (+3.27%)

Closing price 03:58 PM Eastern

Extended Trading

$47.34 -0.04 (-0.08%)

As of 07:59 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest HIMS, LLY, NVO, and AMZN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest HIMS, LLY, NVO, and AMZN Earnings

Compare Dividends

Latest HIMS, LLY, NVO, and AMZN Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

HIMS, LLY, NVO, and AMZN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

HIMS, LLY, NVO, and AMZN Company Descriptions

Amazon.com NASDAQ:AMZN

Hims & Hers Health NYSE:HIMS

Eli Lilly and Company NYSE:LLY

Novo Nordisk A/S NYSE:NVO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools